controllers
发表于 2025-3-21 17:06:22
书目名称Coronary Artery Disease: Therapeutics and Drug Discovery影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0238307<br><br> <br><br>书目名称Coronary Artery Disease: Therapeutics and Drug Discovery读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0238307<br><br> <br><br>
Heretical
发表于 2025-3-21 23:44:07
Evidence in Guidelines for Treatment of Coronary Artery Disease,is discussed, which plays an important role in CAD risk control, including forming healthy dietary pattern, maintaining proper body weight, physical exercise, smoking cessation, and so on. Part 2 elaborated on revascularization strategies and medical treatments in patients presenting with acute coro
BOLT
发表于 2025-3-22 01:21:06
Revascularization for Coronary Artery Disease: Principle and Challenges,r coronary revascularization and discusses the evidence on the mechanisms, indications, techniques, and outcomes of these approaches. Targeting coronary thrombus, fibrinolysis is indicated for patients with diagnosed myocardial infarction and without high risk of severe hemorrhage. The development o
armistice
发表于 2025-3-22 07:10:06
http://reply.papertrans.cn/24/2384/238307/238307_4.png
labyrinth
发表于 2025-3-22 09:37:05
Lipid-Modifying Drugs: Pharmacology and Perspectives,r atherosclerosis and CAD, which results in cardiac ischemic injury and myocardial infarction. Lipid-modifying drugs can effectively improve lipid abnormalities including reducing low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) or increasing high-density lipoprotein cholesterol (H
袭击
发表于 2025-3-22 13:31:58
http://reply.papertrans.cn/24/2384/238307/238307_6.png
袭击
发表于 2025-3-22 19:12:42
Pharmaceutical Treatment for Heart Failure, Currently, HF is divided into three groups which include HF with reduced ejection fraction (HFrEF), HF with preserved ejection fraction (HFpEF) and HF with midrange EF (HFmrEF). Even though major advances have been made in treating HFrEF during the past decades, heart failure is a fatal disease. In
恶名声
发表于 2025-3-22 22:59:44
Drug Discovery for Coronary Artery Disease,recently approved PCSK9 inhibitors, together with antithrombotic drugs have been historically successful in reducing the occurrence of coronary artery disease (CAD), the high incidence of CAD remains imposing the largest disease burden on our healthcare systems. We reviewed cardiovascular drugs rece
reception
发表于 2025-3-23 02:22:01
Book 2020ts and thrombolysis. This chapter also addresses the main therapeutic challenges..The following chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6). Heart failure cons
fibula
发表于 2025-3-23 08:12:42
Coronary Artery Disease: Therapeutics and Drug Discovery